In the U.S, small-cell lung cancer (SCLC) patients do not receive the initial standard-of-care treatment. They were also found to have lower overall survival rates, reveals a new study.
The research was from The University of Texas MD Anderson Cancer Center. The findings, reported in iJAMA Oncology/i, also describe obstacles encountered by patients when receiving cancer treatments, such as their insurance status and socioeconomic factors.
"For patients who received both chemotherapy and radiation, median survival was 18 months....
In the U.S, small-cell lung cancer (SCLC) patients do not receive the initial standard-of-care treatment. They were also found to have lower overall survival rates, reveals a new study.
The research was from The University of Texas MD Anderson Cancer Center. The findings, reported in iJAMA Oncology/i, also describe obstacles encountered by patients when receiving cancer treatments, such as their insurance status and socioeconomic factors.
"For patients who received both chemotherapy and radiation, median survival was 18 months....